Corrigendum to \"Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies\" [Laboratory Investigation 105(2025) 104202].
AuteursZels G, Pabba A, De Schepper M, Geukens T, Van Baelen K, Maetens M, Mahdami A, Leduc S, Isnaldi E, Nguyen HL, Bachir I, Van Cauwenberge J, Borremans K, Weynand B, Biganzoli E, Neven P, Wildiers H, Van Den Bogaert W, Richard F, Desmedt C, Floris G
Prospective comparison between geriatric assessment and clinical evaluation in 200 newly diagnosed older adults with multiple myeloma.
AuteursRaddoux J, Kenis C, Vanhellemont A, Meers S, Mineur P, Vekemans MC, Wu KL, Caers J, Van Eygen K, Kentos A, Depaus J, Put N, Van De Velde A, Claes G, Vlummens P, Maertens V, Meuleman N, Broek IV, Vaes M, Fostier K, Demuynck H, Delforge M
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
AuteursDelbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
AuteursDelbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
AuteursDelbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
